1. Enhanced Efficacy of Immunization with a Foot-and-Mouth Disease Multi-Epitope Subunit Vaccine Using Mannan-Decorated Inulin Microparticles
- Author
-
Ho-Bin Lee, Hui-Shan Li, Seo-Ho Oh, Sang-Kee Kang, Chong-Su Cho, Yun-Jaie Choi, So-Yeon Yoon, Jin-Duck Bok, and Whee-Soo Kim
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_treatment ,0206 medical engineering ,Biomedical Engineering ,Medicine (miscellaneous) ,02 engineering and technology ,Microbiology ,Epitopes ,Mice ,03 medical and health sciences ,Immune system ,Adjuvants, Immunologic ,Antigen ,medicine ,Animals ,Antigens ,skin and connective tissue diseases ,030304 developmental biology ,Mannan ,Vaccines, Synthetic ,0303 health sciences ,biology ,Chemistry ,Immunogenicity ,Vaccination ,Inulin ,Proteolytic enzymes ,nutritional and metabolic diseases ,020601 biomedical engineering ,Immunity, Humoral ,Immunization ,Foot-and-Mouth Disease ,Immunoglobulin G ,Vaccines, Subunit ,biology.protein ,Original Article ,Antibody ,Adjuvant - Abstract
BACKGROUND: Despite the many advantages of recombinant subunit vaccines, they have critical weaknesses that include a low efficacy for promoting cellular and humoral immune responses against antigens because of their poor immunogenicity, and a rapidly cleared properties as a result of proteolytic enzymes in the body. To circumvent these problems, we developed mannan-decorated inulin acetate microparticles (M-IA MPs) that functioned as carriers and adjuvants for immunization with the recombinant foot-and-mouth disease multi-epitope subunit vaccine (M5BT). METHODS: The M5BT-loaded M-IA MPs were obtained by a double-emulsion solvent-evaporation method. Their properties including morphology, size and release ability were determined by field emission scanning electron microscope, dynamic light-scattering spectrophotometer and spectrophotometer. To assess the immunization efficacy of the MPs, mice were immunized with MPs and their sera were analyzed by ELISA. RESULTS: The M-IA MPs obtained by a double-emulsion solvent-evaporation method were spherical and approximately 2–3 µm, and M5BT was encapsulated in the M-IA MPs. The M5BT-loaded M-IA MPs showed higher antigen-specific IgG, IgG1, IgG2a and anti-FMDV antibodies than the M5BT-loaded IA MPs and the Freund’s adjuvant as a control. CONCLUSION: The M-IA MPs showed a powerful and multifunctional polymeric system that combined two toll-like receptor agonists compared to the conventional adjuvant.
- Published
- 2019
- Full Text
- View/download PDF